APA

Fernández-Cruz E., Lang J. M., Frissen J., Furner V., Châteauvert M., Boucher C. A., Dowd P. & Stevens J. (19960130). Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group. : AIDS (London, England).

Chicago

Fernández-Cruz E, Lang J M, Frissen J, Furner V, Châteauvert M, Boucher C A, Dowd P and Stevens J. 19960130. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group. : AIDS (London, England).

Harvard

Fernández-Cruz E., Lang J. M., Frissen J., Furner V., Châteauvert M., Boucher C. A., Dowd P. and Stevens J. (19960130). Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group. : AIDS (London, England).

MLA

Fernández-Cruz E, Lang J M, Frissen J, Furner V, Châteauvert M, Boucher C A, Dowd P and Stevens J. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group. : AIDS (London, England). 19960130.